查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
腦脊髓液管理市場規模和預測、全球和地區佔有率、趨勢和成長機會分析報告範圍：按產品、最終用戶和地理位置
市場調查報告書
商品編碼
1362402

腦脊髓液管理市場規模和預測、全球和地區佔有率、趨勢和成長機會分析報告範圍：按產品、最終用戶和地理位置

Cerebrospinal Fluid Management Market Size and Forecasts, Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Product, End User, and Geography
出版日期: | 出版商: The Insight Partners | 英文 177 Pages | 訂單完成後即時交付

價格

腦脊髓液管理市場規模預計將從2022年的19,1137萬美元增至2030年的2,89,254萬美元；預計2022年至2030年年複合成長率為5.3%。

在過去的幾十年裡，對更好的治療方式的需求不斷成長，導致了各種產品的開發。以下提到了 CSF 管理市場近期產品開發的一些範例。

2022年 9月，Anuncia Medical Inc 的 ReFlow System Mini 獲得美國食品藥物管理局(FDA)批准，用於治療腦積水和其他需要分流的腦脊髓液疾病患者。 ReFlow System Mini 非侵入性地促進腦室導管的沖洗，以恢復、增加或維持分流器中的腦脊髓液流量。

2021年 3月，FDA 授予 Anuncia 用於腦脊髓液管理的 ReFlow 系統突破性設備頭銜。該設備目的是治療需要分流的腦脊髓液疾病，例如腦積水。 ReFlow 系統可用於居家照護環境和診所，以非侵入性方式進行預防性沖洗，以潛在地防止腦脊髓液阻塞。

2020年 6月，FDA 授予 Rhaeos, Inc. 提供的 FlowSense 無線非侵入性流量感測器突破性設備稱號。該產品目的是快速監測腦積水引起的腦脊髓液過多患者的心室分流功能。

神經系統疾病治療中對腦脊髓液管理的日益關注為腦脊髓液管理市場提供了新機會

腦脊髓液參數作為成年患者神經系統疾病的生物標記廣泛評估。腦脊髓液中循環的 microRNA 是一類有前景的生物標記物，可用於診斷各種神經系統疾病。帕金森氏症(PD)、阿茲海默症(AD)、癲癇和癲癇等神經系統疾病通常會導致腦脊髓液參數改變。根據《自然》雜誌發表的一篇文章 ，與正常人相比，診斷為 PD 的患者中發現 76 種腦脊髓液蛋白在結構上發生了變化。本研究還表明，這些腦脊髓液蛋白可用作診斷或治療該疾病的生物標記。 PD 是一種與認知障礙和運動功能喪失相關的神經退化性疾病。根據世界衛生組織(WHO)2022年發布的報告，帕金森氏症的盛行率在過去 25年裡加倍，影響了全球約 1%的 60 歲以上人口。同樣，患有癲癇發作或癲癇持續狀態的患者的一些腦脊髓液參數(例如蛋白質和乳酸濃度)也會發生變化。因此，利用腦脊髓液參數治療癲癇發作或癲癇的各種研發活動進行中。此外，儘管市場上有各種使用CSF檢測阿茲海默症的CSF測定法，但對用於檢測和治療目的的生物標記的需求尚未得到滿足。隨著阿茲海默症和帕金森氏症病例的增加，對腦脊髓液管理設備的需求也隨之增加，因為腦脊髓液漏的病例可能會增加。因此，神經系統疾病盛行率的上升推動使用腦脊髓液管理產品治療這些疾病的研發活動。

腦脊髓液管理市場分為產品和最終用戶。根據產品，市場分為腦脊髓液分流器和腦脊髓液引流系統。2022年，依產品分類，腦脊髓液分流器細分市場佔據最大市場。由於產品推出的增加、對先進腦脊髓液分流器的需求增加以及腦積水發病率的增加，預計同一細分市場在預測期內將以顯著的年複合成長率成長。腦脊髓液分流器進一步分為腦室腹膜分流器、腦室心房分流器、腦室胸膜分流器和腰腹膜分流器。基於腦脊髓液分流術，腦室腹腔分流術在腦脊髓液管理市場中佔有最大的市場佔有率，預計在預測期內將以最快的年複合成長率成長。同樣，腦脊髓液引流系統分為腦室外引流(EVD)系統和腰椎引流(LD)系統。因此，腦室外引流系統是業界最常用的腦脊髓液引流系統，在該領域佔有最大佔有率。

根據地理位置，市場分為北美、歐洲、亞太地區、中東和非洲以及南美洲和中美洲。北美在腦脊髓液管理市場中佔有最大的市場佔有率。由於腦積水、創傷性腦損傷和其他神經系統疾病發病率的增加，預計北美市場在預測期內將繼續佔據主導地位；快速的技術創新；和發展醫療保健基礎設施。由於老年人口不斷成長、對先進醫療設備的需求以及提供有效治療的醫療基礎設施不斷增加等因素，亞太地區成為市場上成長最快的地區。

腦脊髓液管理市場的成長是由關鍵因素決定的，例如腦脊髓液洩漏發生率的增加和腦脊髓液管理產品的不斷發展。另一方面，與腦脊髓液分流相關的風險阻礙了市場的成長。

加拿大傳染病報告(CCDR)、疾病管制與預防中心(CDC)、歐盟、義大利貿易署(ITA)是在準備腦脊髓液管理市場報告時提到的幾個關鍵的主要和次要來源。

目錄

第1章 簡介

  • Insight Partners 研究報告指南
  • 市場區隔

第2章 執行摘要

  • 重要見解

第3章 研究方法

  • 覆蓋範圍
  • 二次研究
  • 初步研究

第4章 腦脊髓液管理市場格局

  • 概述
  • PEST分析
    • 北美 PEST 分析
    • 歐洲PEST分析
    • 亞太地區 PEST 分析
    • 南美洲和中美洲 PEST 分析
    • 中東和非洲 PEST 分析

第5章 腦脊髓液管理市場 - 主要產業動態

  • 市場促進因素
    • 腦脊髓液漏率增加
    • CSF 管理產品不斷發展
  • 市場限制
    • 與腦脊髓液分流術相關的風險
  • 市場機會
    • 越來越關注使用腦脊髓液管理來治療神經系統疾病
  • 未來的趨勢
    • 腦脊髓液分流術的技術發展
  • 影響分析：

第6章 腦脊髓液管理市場 - 全球市場分析

  • 腦脊髓液管理市場收入，2022 -2030

第7章 全球腦脊髓液管理市場 - 收入和2030年預測 - 依產品

  • 概述
  • 2022年及2030年腦脊髓液管理市場收入佔有率(依產品分類)
  • 腦脊髓液分流術
  • 腦脊髓液引流系統

第8章 全球腦脊髓液管理市場 - 收入和2030年預測 - 依最終用戶

  • 概述
  • 2022年及2030年腦脊髓液管理市場收入佔有率(依最終用戶分類)(%)
  • 醫院
  • 診所
  • 門診手術中心
  • 其他

第9章 腦脊髓液管理市場 - 地理分析

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 英國
    • 德國
    • 法國
    • 義大利
    • 西班牙
    • 歐洲其他地區
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 澳洲
    • 韓國
    • 亞太地區其他地區
  • 中東和非洲
    • 阿拉伯聯合大公國
    • 沙烏地阿拉伯
    • 南非
    • 中東和非洲其他地區
  • 南美洲和中美洲
    • 巴西
    • 阿根廷
    • 南美洲和中美洲其他地區

第10章 Covid-19 前後的影響

  • Covid-19 前後的影響

第11章 腦脊髓液管理市場 - 產業格局

  • 概述
  • 2020-2023年腦脊髓液管理市場的成長策略
  • 無機成長策略
    • 概述
  • 有機成長策略
    • 概述

第12章 公司簡介

  • Medtronic Plc
  • Integra LifeSciences Holdings Corp
  • B. Braun SE
  • Argi Group Health Services Ltd Sti
  • Sophysa SA
  • BeckerSmith Medical Inc
  • Delta Surgical Ltd
  • Moller Medical GmbH
  • Natus Medical Inc
  • Spiegelberg GmbH & Co KG

第13章 附錄

  • 關於我們
  • 專業術語
Product Code: TIPRE00004182

The cerebrospinal fluid management market size is expected to reach US$ 2,892.54 million by 2030 from US$ 1,911.37 million in 2022; it is estimated to record a CAGR of 5.3% from 2022 to 2030.

The growing demand for better treatment modalities has resulted in various product developments in the last few decades. A few of the examples of recent product developments in the CSF management market are mentioned below.

In September 2022, Anuncia Medical Inc received US Food and Drug Administration (FDA) approval for its ReFlow System Mini for the treatment of patients with hydrocephalus and other cerebrospinal fluid disorders that require shunting. ReFlow System Mini noninvasively facilitates a flush of ventricular catheters to restore, increase, or maintain CSF flow in a shunt.

In March 2021, the FDA granted a breakthrough device designation for the ReFlow System of Anuncia for CSF management. The device is designed to treat CSF disorders such as hydrocephalus, which require shunting. ReFlow system can be used in homecare settings and in clinics for prophylactic flushing that is performed noninvasively to potentially prevent CSF blockages.

In June 2020, the FDA granted Breakthrough Device Designation to the FlowSense wireless, noninvasive flow sensor offered by Rhaeos, Inc. The product is designed to rapidly monitor ventricular shunt function in patients with excess cerebrospinal fluid caused by hydrocephalus.

Increasing Focus on CSF Management in Neurological Disease Treatments Provides New Opportunities for the Cerebrospinal Fluid Management Market

CSF parameters are extensively evaluated as biomarkers of neurological disorders in adult patients. Circulating microRNAs in CSF are a promising class of biomarkers for the diagnosis of various neurological diseases. Neurological disorders such as Parkinson's Disease (PD), Alzheimer's Disease (AD), epilepsy, and seizures often lead to altered CSF parameters. According to an article published in Nature, 76 CSF proteins were found to be structurally altered in patients that were diagnosed with PD when compared to normal individuals. The study also suggests that these CSF proteins can be used as biomarkers for the diagnosis or treatment of the disease. PD is a neurodegenerative disease associated with loss of cognitive impairment and motor function. According to the World Health Organization (WHO) report published in 2022, the prevalence of PD has doubled in the last 25 years, affecting ~1% of the global population aged more than 60 years. Similarly, a few of the CSF parameters such as protein and lactate levels are altered in patients suffering from seizure or status epilepticus. Therefore, various R&D activities are going on for using CSF parameters in the treatment of seizures or epilepsy. Further, despite the availability of various CSF assays for the detection of Alzheimer's disease using CSF in the market, there are unmet needs for biomarkers for detection and treatment purposes. As the detection of cases of Alzheimer's disease and PD increases, there is increase in demand for CSF management devices as the cases of CSF leaks may increases. Therefore, a rise in the prevalence of neurological disorders is fueling the research and development activities for the use of CSF management products in the treatment of these disorders.

The cerebrospinal fluid management market is segments into product and end user. Based on product, the market is bifurcated into CSF shunts and CSF drainage systems. In 2022, the CSF shunts segment held the largest share of the market by product. and the same segment is estimated to grow at a significant CAGR during the forecast period due to growing product launches, increasing demand for advanced CSF shunts, and increasing incidences of hydrocephalus. CSF shunts was further segmented into ventriculoperitoneal shunts, ventriculoatrial shunts, ventriculopleural shunts, and lumboperitoneal shunts. Based on CSF shunts, ventriculoperitoneal shunts held the largest market share of cerebrospinal fluid management market and is expected to grow at a fastest CAGR during the forecast period. Similarly, the CSF drainage systems were classified into external ventricular drainage (EVD) systems and lumbar drainage (LD) systems. External ventricular drainage systems are the more commonly used CSF drainage systems in the industry therefore, marking largest share of the segment.

Based on geography, the market is segmented into North America, Europe, Asia Pacific Middle East & Africa, and South & Central America. North America held the largest market share of the cerebrospinal fluid management market. The market in North America is expected to continue its dominance during the forecast period due to the increasing hydrocephalus, traumatic brain injury, and other neurological condition incidences; rapid technological innovations; and developing healthcare infrastructure. Whereas Asia Pacific is the fastest growing region in the market owing to the factors, including growing geriatric population, demand for advanced medical devices, and increasing healthcare infrastructures offering efficient treatments.

The growth of cerebrospinal fluid management market is defined by some of the key factors, such as increasing incidences of CSF leak and growing developments for CSF management products. On the other hand, the risk associated with CSF shunts hinders the market growth.

The Canada Communicable Disease Report (CCDR), Centers for Disease Control and Prevention (CDC), European Union, Italian Trade Agency (ITA) are a few key primary and secondary sources referred to while preparing the report on the cerebrospinal fluid management market.

Reasons to Buy:

  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players, and segments in the cerebrospinal fluid management.
  • Highlights key business priorities in order to assist companies to realign their business strategies.
  • The key findings and recommendations highlight crucial progressive industry trends in the global cerebrospinal fluid management, thereby allowing players across the value chain to develop effective long-term strategies.
  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.
  • Scrutinize in-depth global cerebrospinal fluid management trends and outlook coupled with the factors driving the market, as well as those hindering it.
  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

Table Of Contents

1. Introduction

  • 1.1 The Insight Partners Research Report Guidance
  • 1.2 Market Segmentation

2. Executive Summary

  • 2.1 Key Insights

3. Research Methodology

  • 3.1 Coverage
  • 3.2 Secondary Research
  • 3.3 Primary Research

4. Cerebrospinal Fluid Management Market Landscape

  • 4.1 Overview
  • 4.2 PEST Analysis
    • 4.2.1 North America PEST Analysis
    • 4.2.2 Europe PEST Analysis
    • 4.2.3 Asia Pacific PEST Analysis
    • 4.2.4 South & Central America PEST Analysis
    • 4.2.5 Middle East & Africa PEST Analysis

5. Cerebrospinal Fluid Management Market - Key Industry Dynamics

  • 5.1 Market Drivers
    • 5.1.1 Increasing Incidences of CSF Leak
    • 5.1.2 Growing Developments for CSF Management Products
  • 5.2 Market Restraints
    • 5.2.1 Risk Associated with CSF Shunts
  • 5.3 Market Opportunities
    • 5.3.1 Increasing Focus on Use of CSF Management for Treatment of Neurological Diseases
  • 5.4 Future Trends
    • 5.4.1 Technological Developments for CSF Shunts
  • 5.5 Impact Analysis:

6. Cerebrospinal Fluid Management Market - Global Market Analysis

  • 6.1 Cerebrospinal Fluid Management Market Revenue (US$ Mn), 2022 - 2030

7. Global Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 - by Product

  • 7.1 Overview
  • 7.2 Cerebrospinal Fluid Management Market Revenue Share, by Product 2022 & 2030 (%)
  • 7.3 CSF Shunts
    • 7.3.1 Overview
    • 7.3.2 CSF Shunts: Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
    • 7.3.3 Ventriculoperitoneal Shunts
      • 7.3.3.1 Overview
      • 7.3.3.2 Ventriculoperitoneal Shunts: Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
    • 7.3.4 Ventriculoatrial Shunts
      • 7.3.4.1 Overview
      • 7.3.4.2 Ventriculoatrial Shunts: Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
    • 7.3.5 Ventriculopleural Shunts
      • 7.3.5.1 Overview
      • 7.3.5.2 Ventriculopleural Shunts: Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
    • 7.3.6 Lumboperitoneal Shunts
      • 7.3.6.1 Overview
      • 7.3.6.2 Lumboperitoneal Shunts: Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
  • 7.4 CSF Drainage Systems
    • 7.4.1 Overview
    • 7.4.2 CSF Drainage Systems: Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
    • 7.4.3 External Ventricular Drainage (EVD) Systems
      • 7.4.3.1 Overview
      • 7.4.3.2 External Ventricular Drainage (EVD) Systems: Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
    • 7.4.4 Lumbar Drainage (LD) Systems
      • 7.4.4.1 Overview
      • 7.4.4.2 Lumbar Drainage (LD) Systems: Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)

8. Global Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 - by End User

  • 8.1 Overview
  • 8.2 Cerebrospinal Fluid Management Market Revenue Share, by End User 2022 & 2030 (%)
  • 8.3 Hospitals
    • 8.3.1 Overview
    • 8.3.2 Hospitals: Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.4 Clinics
    • 8.4.1 Overview
    • 8.4.2 Clinics: Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.5 Ambulatory Surgical Centers
    • 8.5.1 Overview
    • 8.5.2 Ambulatory Surgical Centers: Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
  • 8.6 Others
    • 8.6.1 Overview
    • 8.6.2 Others: Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)

9. Cerebrospinal Fluid Management Market - Geographical Analysis

  • 9.1 North America Cerebrospinal Fluid Management Market, Revenue and Forecast To 2030
    • 9.1.1 Overview
    • 9.1.2 North America Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
      • 9.1.2.1 North America Cerebrospinal Fluid Management Market, by Product
        • 9.1.2.1.1 North America Cerebrospinal Fluid Management Market, by CSF Shunts
        • 9.1.2.1.2 North America Cerebrospinal Fluid Management Market, by CSF Drainage Systems
      • 9.1.2.2 North America Cerebrospinal Fluid Management Market, by End User
      • 9.1.2.3 North America Cerebrospinal Fluid Management Market, by Country
      • 9.1.2.4 US
        • 9.1.2.4.1 Overview
        • 9.1.2.4.2 US Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.1.2.4.3 US Cerebrospinal Fluid Management Market, by Product
        • 9.1.2.4.3.1 US Cerebrospinal Fluid Management Market, by CSF Shunts
        • 9.1.2.4.3.2 US Cerebrospinal Fluid Management Market, by CSF Drainage Systems
        • 9.1.2.4.4 US Cerebrospinal Fluid Management Market, by End User
      • 9.1.2.5 Canada
        • 9.1.2.5.1 Overview
        • 9.1.2.5.2 Canada Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.1.2.5.3 Canada Cerebrospinal Fluid Management Market, by Product
        • 9.1.2.5.3.1 Canada Cerebrospinal Fluid Management Market, by CSF Shunts
        • 9.1.2.5.3.2 Canada Cerebrospinal Fluid Management Market, by CSF Drainage Systems
        • 9.1.2.5.4 Canada Cerebrospinal Fluid Management Market, by End User
      • 9.1.2.6 Mexico
        • 9.1.2.6.1 Overview
        • 9.1.2.6.2 Mexico Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.1.2.6.3 Mexico Cerebrospinal Fluid Management Market, by Product
        • 9.1.2.6.3.1 Mexico Cerebrospinal Fluid Management Market, by CSF Shunts
        • 9.1.2.6.3.2 Mexico Cerebrospinal Fluid Management Market, by CSF Drainage Systems
        • 9.1.2.6.4 Mexico Cerebrospinal Fluid Management Market, by End User
  • 9.2 Europe Cerebrospinal Fluid Management Market, Revenue and Forecast to 2030
    • 9.2.1 Overview
    • 9.2.2 Europe Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
      • 9.2.2.1 Europe Cerebrospinal Fluid Management Market, by Product
        • 9.2.2.1.1 Europe Cerebrospinal Fluid Management Market, by CSF Shunts
        • 9.2.2.1.2 Europe Cerebrospinal Fluid Management Market, by CSF Drainage Systems
      • 9.2.2.2 Europe Cerebrospinal Fluid Management Market, by End User
      • 9.2.2.3 Europe Cerebrospinal Fluid Management Market, by Country
      • 9.2.2.4 UK
        • 9.2.2.4.1 Overview
        • 9.2.2.4.2 UK Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.2.2.4.3 UK Cerebrospinal Fluid Management Market, by Product
        • 9.2.2.4.3.1 UK Cerebrospinal Fluid Management Market, by CSF Shunts
        • 9.2.2.4.3.2 UK Cerebrospinal Fluid Management Market, by CSF Drainage Systems
        • 9.2.2.4.4 UK Cerebrospinal Fluid Management Market, by End User
      • 9.2.2.5 Germany
        • 9.2.2.5.1 Overview
        • 9.2.2.5.2 Germany Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.2.2.5.3 Germany Cerebrospinal Fluid Management Market, by Product
        • 9.2.2.5.3.1 Germany Cerebrospinal Fluid Management Market, by CSF Shunts
        • 9.2.2.5.3.2 Germany Cerebrospinal Fluid Management Market, by CSF Drainage Systems
        • 9.2.2.5.4 Germany Cerebrospinal Fluid Management Market, by End User
      • 9.2.2.6 France
        • 9.2.2.6.1 Overview
        • 9.2.2.6.2 France Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.2.2.6.3 France Cerebrospinal Fluid Management Market, by Product
        • 9.2.2.6.3.1 France Cerebrospinal Fluid Management Market, by CSF Shunts
        • 9.2.2.6.3.2 France Cerebrospinal Fluid Management Market, by CSF Drainage Systems
        • 9.2.2.6.4 France Cerebrospinal Fluid Management Market, by End User
      • 9.2.2.7 Italy
        • 9.2.2.7.1 Overview
        • 9.2.2.7.2 Italy Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.2.2.7.3 Italy Cerebrospinal Fluid Management Market, by Product
        • 9.2.2.7.3.1 Italy Cerebrospinal Fluid Management Market, by CSF Shunts
        • 9.2.2.7.3.2 Italy Cerebrospinal Fluid Management Market, by CSF Drainage Systems
        • 9.2.2.7.4 Italy Cerebrospinal Fluid Management Market, by End User
      • 9.2.2.8 Spain
        • 9.2.2.8.1 Overview
        • 9.2.2.8.2 Spain Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.2.2.8.3 Spain Cerebrospinal Fluid Management Market, by Product
        • 9.2.2.8.3.1 Spain Cerebrospinal Fluid Management Market, by CSF Shunts
        • 9.2.2.8.3.2 Spain Cerebrospinal Fluid Management Market, by CSF Drainage Systems
        • 9.2.2.8.4 Spain Cerebrospinal Fluid Management Market, by End User
      • 9.2.2.9 Rest of Europe
        • 9.2.2.9.1 Overview
        • 9.2.2.9.2 Rest of Europe Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.2.2.9.3 Rest of Europe Cerebrospinal Fluid Management Market, by Product
        • 9.2.2.9.3.1 Rest of Europe Cerebrospinal Fluid Management Market, by CSF Shunts
        • 9.2.2.9.3.2 Rest of Europe Cerebrospinal Fluid Management Market, by CSF Drainage Systems
        • 9.2.2.9.4 Rest of Europe Cerebrospinal Fluid Management Market, by End User
  • 9.3 Asia Pacific Cerebrospinal Fluid Management Market, Revenue and Forecast to 2030
    • 9.3.1 Overview
    • 9.3.2 Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
      • 9.3.2.1 Asia Pacific Cerebrospinal Fluid Management Market, by Product
        • 9.3.2.1.1 Asia Pacific Cerebrospinal Fluid Management Market, by CSF Shunts
        • 9.3.2.1.2 Asia Pacific Cerebrospinal Fluid Management Market, by CSF Drainage Systems
      • 9.3.2.2 Asia Pacific Cerebrospinal Fluid Management Market, by End User
      • 9.3.2.3 Asia Pacific Cerebrospinal Fluid Management Market, by Country
      • 9.3.2.4 China
        • 9.3.2.4.1 Overview
        • 9.3.2.4.2 China Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.3.2.4.3 China Cerebrospinal Fluid Management Market, by Product
        • 9.3.2.4.3.1 China Cerebrospinal Fluid Management Market, by CSF Shunts
        • 9.3.2.4.3.2 China Cerebrospinal Fluid Management Market, by CSF Drainage Systems
        • 9.3.2.4.4 China Cerebrospinal Fluid Management Market, by End User
      • 9.3.2.5 Japan
        • 9.3.2.5.1 Overview
        • 9.3.2.5.2 Japan Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.3.2.5.3 Japan Cerebrospinal Fluid Management Market, by Product
        • 9.3.2.5.3.1 Japan Cerebrospinal Fluid Management Market, by CSF Shunts
        • 9.3.2.5.3.2 Japan Cerebrospinal Fluid Management Market, by CSF Drainage Systems
        • 9.3.2.5.4 Japan Cerebrospinal Fluid Management Market, by End User
      • 9.3.2.6 India
        • 9.3.2.6.1 Overview
        • 9.3.2.6.2 India Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.3.2.6.3 India Cerebrospinal Fluid Management Market, by Product
        • 9.3.2.6.3.1 India Cerebrospinal Fluid Management Market, by CSF Shunts
        • 9.3.2.6.3.2 India Cerebrospinal Fluid Management Market, by CSF Drainage Systems
        • 9.3.2.6.4 India Cerebrospinal Fluid Management Market, by End User
      • 9.3.2.7 Australia
        • 9.3.2.7.1 Overview
        • 9.3.2.7.2 Australia Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.3.2.7.3 Australia Cerebrospinal Fluid Management Market, by Product
        • 9.3.2.7.3.1 Australia Cerebrospinal Fluid Management Market, by CSF Shunts
        • 9.3.2.7.3.2 Australia Cerebrospinal Fluid Management Market, by CSF Drainage Systems
        • 9.3.2.7.4 Australia Cerebrospinal Fluid Management Market, by End User
      • 9.3.2.8 South Korea
        • 9.3.2.8.1 Overview
        • 9.3.2.8.2 South Korea Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.3.2.8.3 South Korea Cerebrospinal Fluid Management Market, by Product
        • 9.3.2.8.3.1 South Korea Cerebrospinal Fluid Management Market, by CSF Shunts
        • 9.3.2.8.3.2 South Korea Cerebrospinal Fluid Management Market, by CSF Drainage Systems
        • 9.3.2.8.4 South Korea Cerebrospinal Fluid Management Market, by End User
      • 9.3.2.9 Rest of Asia Pacific
        • 9.3.2.9.1 Overview
        • 9.3.2.9.2 Rest of Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.3.2.9.3 Rest of Asia Pacific Cerebrospinal Fluid Management Market, by Product
        • 9.3.2.9.3.1 Rest of Asia Pacific Cerebrospinal Fluid Management Market, by CSF Shunts
        • 9.3.2.9.3.2 Rest of Asia Pacific Cerebrospinal Fluid Management Market, by CSF Drainage Systems
        • 9.3.2.9.4 Rest of Asia Pacific Cerebrospinal Fluid Management Market, by End User
  • 9.4 Middle East & Africa Cerebrospinal Fluid Management Market, Revenue and Forecast to 2030
    • 9.4.1 Overview
    • 9.4.2 Middle East & Africa Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
      • 9.4.2.1 Middle East & Africa Cerebrospinal Fluid Management Market, by Product
        • 9.4.2.1.1 Middle East & Africa Cerebrospinal Fluid Management Market, by CSF Shunts
        • 9.4.2.1.2 Middle East & Africa Cerebrospinal Fluid Management Market, by CSF Drainage Systems
      • 9.4.2.2 Middle East & Africa Cerebrospinal Fluid Management Market, by End User
      • 9.4.2.3 Middle East & Africa Cerebrospinal Fluid Management Market, by Country
      • 9.4.2.4 UAE
        • 9.4.2.4.1 Overview
        • 9.4.2.4.2 UAE Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.4.2.4.3 UAE Cerebrospinal Fluid Management Market, by Product
        • 9.4.2.4.3.1 UAE Cerebrospinal Fluid Management Market, by CSF Shunts
        • 9.4.2.4.3.2 UAE Cerebrospinal Fluid Management Market, by CSF Drainage Systems
        • 9.4.2.4.4 UAE Cerebrospinal Fluid Management Market, by End User
      • 9.4.2.5 Saudi Arabia
        • 9.4.2.5.1 Overview
        • 9.4.2.5.2 Saudi Arabia Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.4.2.5.3 Saudi Arabia Cerebrospinal Fluid Management Market, by Product
        • 9.4.2.5.3.1 Saudi Arabia Cerebrospinal Fluid Management Market, by CSF Shunts
        • 9.4.2.5.3.2 Saudi Arabia Cerebrospinal Fluid Management Market, by CSF Drainage Systems
        • 9.4.2.5.4 Saudi Arabia Cerebrospinal Fluid Management Market, by End User
      • 9.4.2.6 South Africa
        • 9.4.2.6.1 Overview
        • 9.4.2.6.2 South Africa Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.4.2.6.3 South Africa Cerebrospinal Fluid Management Market, by Product
        • 9.4.2.6.3.1 South Africa Cerebrospinal Fluid Management Market, by CSF Shunts
        • 9.4.2.6.3.2 South Africa Cerebrospinal Fluid Management Market, by CSF Drainage Systems
        • 9.4.2.6.4 South Africa Cerebrospinal Fluid Management Market, by End User
      • 9.4.2.7 Rest of Middle East & Africa
        • 9.4.2.7.1 Overview
        • 9.4.2.7.2 Rest of Middle East & Africa Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.4.2.7.3 Rest of Middle East & Africa Cerebrospinal Fluid Management Market, by Product
        • 9.4.2.7.3.1 Rest of Middle East & Africa Cerebrospinal Fluid Management Market, by CSF Shunts
        • 9.4.2.7.3.2 Rest of Middle East & Africa Cerebrospinal Fluid Management Market, by CSF Drainage Systems
        • 9.4.2.7.4 Rest of Middle East & Africa Cerebrospinal Fluid Management Market, by End User
  • 9.5 South & Central America Cerebrospinal Fluid Management Market, Revenue and Forecast to 2030
    • 9.5.1 Overview
    • 9.5.2 South & Central America Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
      • 9.5.2.1 South & Central America Cerebrospinal Fluid Management Market, by Product
        • 9.5.2.1.1 South & Central America Cerebrospinal Fluid Management Market, by CSF Shunts
        • 9.5.2.1.2 South & Central America Cerebrospinal Fluid Management Market, by CSF Drainage Systems
      • 9.5.2.2 South & Central America Cerebrospinal Fluid Management Market, by End User
      • 9.5.2.3 South & Central America Cerebrospinal Fluid Management Market, by Country
      • 9.5.2.4 Brazil
        • 9.5.2.4.1 Overview
        • 9.5.2.4.2 Brazil Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.5.2.4.3 Brazil Cerebrospinal Fluid Management Market, by Product
        • 9.5.2.4.3.1 Brazil Cerebrospinal Fluid Management Market, by CSF Shunts
        • 9.5.2.4.3.2 Brazil Cerebrospinal Fluid Management Market, by CSF Drainage Systems
        • 9.5.2.4.4 Brazil Cerebrospinal Fluid Management Market, by End User
      • 9.5.2.5 Argentina
        • 9.5.2.5.1 Overview
        • 9.5.2.5.2 Argentina Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.5.2.5.3 Argentina Cerebrospinal Fluid Management Market, by Product
        • 9.5.2.5.3.1 Argentina Cerebrospinal Fluid Management Market, by CSF Shunts
        • 9.5.2.5.3.2 Argentina Cerebrospinal Fluid Management Market, by CSF Drainage Systems
        • 9.5.2.5.4 Argentina Cerebrospinal Fluid Management Market, by End User
      • 9.5.2.6 Rest of South & Central America
        • 9.5.2.6.1 Overview
        • 9.5.2.6.2 Rest of South & Central America Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
        • 9.5.2.6.3 Rest of South & Central America Cerebrospinal Fluid Management Market, by Product
        • 9.5.2.6.3.1 Rest of South & Central America Cerebrospinal Fluid Management Market, by CSF Shunts
        • 9.5.2.6.3.2 Rest of South & Central America Cerebrospinal Fluid Management Market, by CSF Drainage Systems
        • 9.5.2.6.4 Rest of South & Central America Cerebrospinal Fluid Management Market, by End User

10. Pre & Post Covid-19 Impact

  • 10.1 Pre & Post Covid-19 Impact

11. Cerebrospinal Fluid Management Market -Industry Landscape

  • 11.1 Overview
  • 11.2 Growth Strategies in The Cerebrospinal Fluid Management Market, 2020-2023
  • 11.3 Inorganic Growth Strategies
    • 11.3.1 Overview
  • 11.4 Organic Growth Strategies
    • 11.4.1 Overview

12. Company Profiles

  • 12.1 Medtronic Plc
    • 12.1.1 Key Facts
    • 12.1.2 Business Description
    • 12.1.3 Products and Services
    • 12.1.4 Financial Overview
    • 12.1.5 SWOT Analysis
    • 12.1.6 Key Developments
  • 12.2 Integra LifeSciences Holdings Corp
    • 12.2.1 Key Facts
    • 12.2.2 Business Description
    • 12.2.3 Products and Services
    • 12.2.4 Financial Overview
    • 12.2.5 SWOT Analysis
    • 12.2.6 Key Developments
  • 12.3 B. Braun SE
    • 12.3.1 Key Facts
    • 12.3.2 Business Description
    • 12.3.3 Products and Services
    • 12.3.4 Financial Overview
    • 12.3.5 SWOT Analysis
    • 12.3.6 Key Developments
  • 12.4 Argi Group Health Services Ltd Sti
    • 12.4.1 Key Facts
    • 12.4.2 Business Description
    • 12.4.3 Products and Services
    • 12.4.4 Financial Overview
    • 12.4.5 SWOT Analysis
    • 12.4.6 Key Developments
  • 12.5 Sophysa SA
    • 12.5.1 Key Facts
    • 12.5.2 Business Description
    • 12.5.3 Products and Services
    • 12.5.4 Financial Overview
    • 12.5.5 SWOT Analysis
    • 12.5.6 Key Developments
  • 12.6 BeckerSmith Medical Inc
    • 12.6.1 Key Facts
    • 12.6.2 Business Description
    • 12.6.3 Products and Services
    • 12.6.4 Financial Overview
    • 12.6.5 SWOT Analysis
    • 12.6.6 Key Developments
  • 12.7 Delta Surgical Ltd
    • 12.7.1 Key Facts
    • 12.7.2 Business Description
    • 12.7.3 Products and Services
    • 12.7.4 Financial Overview
    • 12.7.5 SWOT Analysis
    • 12.7.6 Key Developments
  • 12.8 Moller Medical GmbH
    • 12.8.1 Key Facts
    • 12.8.2 Business Description
    • 12.8.3 Products and Services
    • 12.8.4 Financial Overview
    • 12.8.5 SWOT Analysis
    • 12.8.6 Key Developments
  • 12.9 Natus Medical Inc
    • 12.9.1 Key Facts
    • 12.9.2 Business Description
    • 12.9.3 Products and Services
    • 12.9.4 Financial Overview
    • 12.9.5 SWOT Analysis
    • 12.9.6 Key Developments
  • 12.10 Spiegelberg GmbH & Co KG
    • 12.10.1 Key Facts
    • 12.10.2 Business Description
    • 12.10.3 Products and Services
    • 12.10.4 Financial Overview
    • 12.10.5 SWOT Analysis
    • 12.10.6 Key Developments

13. Appendix

  • 13.1 About Us
  • 13.2 Glossary of Terms

List Of Tables

  • Table 1. Cerebrospinal Fluid Management Market Segmentation
  • Table 2. North America Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - Product
  • Table 3. North America Cerebrospinal Fluid Management Market Revenue and Forecast To 2028 (US$ Mn) - CSF Shunts
  • Table 4. North America Cerebrospinal Fluid Management Market Revenue and Forecast To 2028 (US$ Mn) - CSF Drainage Systems
  • Table 5. North America Cerebrospinal Fluid Management Market Revenue and Forecast To 2028 (US$ Mn) - End User
  • Table 6. US Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - Product
  • Table 7. US Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - CSF Shunts
  • Table 8. US Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - CSF Drainage Systems
  • Table 9. US Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - End User
  • Table 10. Canada Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - Product
  • Table 11. Canada Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - CSF Shunts
  • Table 12. Canada Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - CSF Drainage Systems
  • Table 13. Canada Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - End User
  • Table 14. Mexico Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - Product
  • Table 15. Mexico Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - CSF Shunts
  • Table 16. Mexico Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - CSF Drainage Systems
  • Table 17. Mexico Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - End User
  • Table 18. Europe Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - Product
  • Table 19. Europe Cerebrospinal Fluid Management Market Revenue and Forecast To 2028 (US$ Mn) - CSF Shunts
  • Table 20. Europe Cerebrospinal Fluid Management Market Revenue and Forecast To 2028 (US$ Mn) - CSF Drainage Systems
  • Table 21. Europe Cerebrospinal Fluid Management Market Revenue and Forecast To 2028 (US$ Mn) - End User
  • Table 22. UK Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - Product
  • Table 23. UK Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - CSF Shunts
  • Table 24. UK Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - CSF Drainage Systems
  • Table 25. UK Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - End User
  • Table 26. Germany Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - Product
  • Table 27. Germany Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - CSF Shunts
  • Table 28. Germany Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - CSF Drainage Systems
  • Table 29. Germany Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - End User
  • Table 30. France Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - Product
  • Table 31. France Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - CSF Shunts
  • Table 32. France Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - CSF Drainage Systems
  • Table 33. France Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - End User
  • Table 34. Italy Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - Product
  • Table 35. Italy Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - CSF Shunts
  • Table 36. Italy Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - CSF Drainage Systems
  • Table 37. Italy Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - End User
  • Table 38. Spain Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - Product
  • Table 39. Spain Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - CSF Shunts
  • Table 40. Spain Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - CSF Drainage Systems
  • Table 41. Spain Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - End User
  • Table 42. Rest of Europe Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - Product
  • Table 43. Rest of Europe Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - CSF Shunts
  • Table 44. Rest of Europe Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - CSF Drainage Systems
  • Table 45. Rest of Europe Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - End User
  • Table 46. Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - Product
  • Table 47. Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast To 2028 (US$ Mn) - CSF Shunts
  • Table 48. Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast To 2028 (US$ Mn) - CSF Drainage Systems
  • Table 49. Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast To 2028 (US$ Mn) - End User
  • Table 50. China Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - Product
  • Table 51. China Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - CSF Shunts
  • Table 52. China Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - CSF Drainage Systems
  • Table 53. China Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - End User
  • Table 54. Japan Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - Product
  • Table 55. Japan Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - CSF Shunts
  • Table 56. Japan Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - CSF Drainage Systems
  • Table 57. Japan Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - End User
  • Table 58. India Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - Product
  • Table 59. India Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - CSF Shunts
  • Table 60. India Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - CSF Drainage Systems
  • Table 61. India Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - End User
  • Table 62. Australia Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - Product
  • Table 63. Australia Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - CSF Shunts
  • Table 64. Australia Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - CSF Drainage Systems
  • Table 65. Australia Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - End User
  • Table 66. South Korea Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - Product
  • Table 67. South Korea Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - CSF Shunts
  • Table 68. South Korea Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - CSF Drainage Systems
  • Table 69. South Korea Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - End User
  • Table 70. Rest of Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - Product
  • Table 71. Rest of Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - CSF Shunts
  • Table 72. Rest of Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - CSF Drainage Systems
  • Table 73. Rest of Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - End User
  • Table 74. Middle East & Africa Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - Product
  • Table 75. Middle East & Africa Cerebrospinal Fluid Management Market Revenue and Forecast To 2028 (US$ Mn) - CSF Shunts
  • Table 76. Middle East & Africa Cerebrospinal Fluid Management Market Revenue and Forecast To 2028 (US$ Mn) - CSF Drainage Systems
  • Table 77. Middle East & Africa Cerebrospinal Fluid Management Market Revenue and Forecast To 2028 (US$ Mn) - End User
  • Table 78. UAE Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - Product
  • Table 79. UAE Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - CSF Shunts
  • Table 80. UAE Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - CSF Drainage Systems
  • Table 81. UAE Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - End User
  • Table 82. Saudi Arabia Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - Product
  • Table 83. Saudi Arabia Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - CSF Shunts
  • Table 84. Saudi Arabia Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - CSF Drainage Systems
  • Table 85. Saudi Arabia Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - End User
  • Table 86. South Africa Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - Product
  • Table 87. South Africa Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - CSF Shunts
  • Table 88. South Africa Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - CSF Drainage Systems
  • Table 89. South Africa Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - End User
  • Table 90. Rest of Middle East & Africa Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - Product
  • Table 91. Rest of Middle East & Africa Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - CSF Shunts
  • Table 92. Rest of Middle East & Africa Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - CSF Drainage Systems
  • Table 93. Rest of Middle East & Africa Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - End User
  • Table 94. South & Central America Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - Product
  • Table 95. South & Central America Cerebrospinal Fluid Management Market Revenue and Forecast To 2028 (US$ Mn) - CSF Shunts
  • Table 96. South & Central America Cerebrospinal Fluid Management Market Revenue and Forecast To 2028 (US$ Mn) - CSF Drainage Systems
  • Table 97. South & Central America Cerebrospinal Fluid Management Market Revenue and Forecast To 2028 (US$ Mn) - End User
  • Table 98. Brazil Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - Product
  • Table 99. Brazil Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - CSF Shunts
  • Table 100. Brazil Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - CSF Drainage Systems
  • Table 101. Brazil Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - End User
  • Table 102. Argentina Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - Product
  • Table 103. Argentina Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - CSF Shunts
  • Table 104. Argentina Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - CSF Drainage Systems
  • Table 105. Argentina Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - End User
  • Table 106. Rest of South & Central America Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - Product
  • Table 107. Rest of South & Central America Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - CSF Shunts
  • Table 108. Rest of South & Central America Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - CSF Drainage Systems
  • Table 109. Rest of South & Central America Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn) - End User
  • Table 110. Recent Inorganic Growth Strategies in the Cerebrospinal Fluid Management Market
  • Table 111. Recent Organic Growth Strategies in The Cerebrospinal Fluid Management Market
  • Table 112. Glossary of Terms, Cerebrospinal Fluid Management Market

List Of Figures

  • Figure 1. Cerebrospinal Fluid Management Market Segmentation, By Geography
  • Figure 2. North America - PEST Analysis
  • Figure 3. Europe - PEST Analysis
  • Figure 4. Asia Pacific - PEST Analysis
  • Figure 5. South & Central America - PEST Analysis
  • Figure 6. Middle East & Africa - PEST Analysis
  • Figure 7. Cerebrospinal Fluid Management Market - Key Industry Dynamics
  • Figure 8. Impact Analysis of Drivers and Restraints
  • Figure 9. Cerebrospinal Fluid Management Market Revenue (US$ Mn), 2022 - 2030
  • Figure 10. Cerebrospinal Fluid Management Market Revenue, Geography (US$ Mn), 2022 - 2030
  • Figure 11. Cerebrospinal Fluid Management Market Revenue Share, by Product 2022 & 2030 (%)
  • Figure 12. CSF Shunts: Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 13. Ventriculoperitoneal Shunts: Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 14. Ventriculoatrial Shunts: Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 15. Ventriculopleural Shunts: Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 16. Lumboperitoneal Shunts: Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 17. CSF Drainage Systems: Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 18. External Ventricular Drainage (EVD) Systems: Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 19. Lumbar Drainage (LD) Systems: Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 20. Cerebrospinal Fluid Management Market Revenue Share, by End User 2022 & 2030 (%)
  • Figure 21. Hospitals: Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 22. Clinics: Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 23. Ambulatory Surgical Centers: Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 24. Others: Cerebrospinal Fluid Management Market - Revenue and Forecast to 2030 (US$ Million)
  • Figure 25. Cerebrospinal Fluid Management Market, 2022 ($Mn)
  • Figure 26. North America Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 27. North America Cerebrospinal Fluid Management Market, By Key Countries, 2022 and 2030 (%)
  • Figure 28. US Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 29. Canada Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 30. Mexico Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 31. Europe Cerebrospinal Fluid Management Market, By Geography, 2022 ($Mn)
  • Figure 32. Europe Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 33. Europe Cerebrospinal Fluid Management Market, By Key Countries, 2022 and 2030 (%)
  • Figure 34. UK Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 35. Germany Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 36. France Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 37. Italy Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 38. Spain Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 39. Rest of Europe Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 40. Cerebrospinal Fluid Management Market, By Geography, 2022 ($Mn)
  • Figure 41. Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 42. Asia Pacific Cerebrospinal Fluid Management Market, By Key Countries, 2022 and 2030 (%)
  • Figure 43. China Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 44. Japan Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 45. India Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 46. Australia Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 47. South Korea Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 48. Rest of Asia Pacific Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 49. Cerebrospinal Fluid Management Market, By Geography, 2022 and 2030 ($Mn)
  • Figure 50. Middle East & Africa Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 51. Middle East & Africa Cerebrospinal Fluid Management Market, By Key Countries, 2022 and 2030 (%)
  • Figure 52. UAE Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 53. Saudi Arabia Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 54. South Africa Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 55. Rest of Middle East & Africa Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 56. Cerebrospinal Fluid Management Market, By Geography, 2022 ($Mn)
  • Figure 57. South & Central America Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 58. South & Central America Cerebrospinal Fluid Management Market, By Key Countries, 2022 and 2030 (%)
  • Figure 59. Brazil Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 60. Argentina Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 61. Rest of South & Central America Cerebrospinal Fluid Management Market Revenue and Forecast to 2030 (US$ Mn)
  • Figure 62. Pre & Post Covid-19 Impact
  • Figure 63. Growth Strategies in The Cerebrospinal Fluid Management Market, 2020-2023